Completed PHASE3 INTERVENTIONAL NCT00512811

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients

Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study

Sponsor: Baqiyatallah Medical Sciences University

Interventions furosemide

Updated 6 times since 2017 Last updated: Aug 7, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Bronchiolitis and is currently completed. Baqiyatallah Medical Sciences University leads this study, which shows 6 recorded versions since 2026 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baqiyatallah Medical Sciences University

Data source: Baqiyatallah Medical Sciences University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehran, Iran